Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On November 4, 2020, the Board of Directors (the "Board") of Tenet Healthcare
Corporation (the "Company") appointed the Company's President and Chief
Operating Officer, Saum Sutaria, M.D., to the Board effective immediately. The
size of the Board increased from ten to eleven directors upon the effectiveness
of Dr. Sutaria's appointment. Dr. Sutaria's initial term will expire
concurrently with the terms of the other members of the Board, and Board members
will stand for annual election at the Company's 2021 Annual Meeting of
Shareholders. Dr. Sutaria will not serve on any committee of the Board.
As an executive officer of the Company, Dr. Sutaria will not receive
compensation for his service on the Board. Dr. Sutaria is not party to any
material plan, contract, or arrangement with the Company other than those
related to his compensation as described in the Company's proxy statement filed
with the Securities and Exchange Commission on April 17, 2020. There are no
arrangements or understandings pursuant to which Dr. Sutaria was appointed to
the Board, and Dr. Sutaria is not a party to any transaction with the Company
reportable under Item 404(a) of Regulation S-K under the Securities Act of 1933.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses